Table 1.
Demographical and clinical characteristics of participants.
| Variables | Overall (N = 93) N (%) |
TB-only (n = 59) n, (%) | TBDM (n = 34) n, (%) | p-value |
|---|---|---|---|---|
| Gender (Male) | 63 (67.7) | 43 (68.3) | 20 (31.7) | 0.163 |
| Age (Years) | ||||
| 15-25 | 16 (17.2) | 16 (27.1) | 0 (0.0) | <0.001 |
| 26-40 | 30 (32.3) | 23 (39.0) | 7 (20.6) | |
| 41-60 | 32 (34.4) | 13 (22.0) | 19 (55.9) | |
| Over 60 | 15 (16.1) | 7 (11.9) | 8 (23.5) | |
| TB status (n = 91) | ||||
| New case | 85 (93.4) | 55 (94.8) | 30 (90.9) | 0.325 |
| Relapse | 6 (6.6) | 3 (5.2) | 3 (9.1) | |
| Alcohol use (Yes) | 60 (64.5) | 39 (66.1) | 21 (61.8) | 0.674 |
| Smoking (Yes) | 26 (28.0) | 18 (30.5) | 8 (23.5) | 0.470 |
| Mycobacterium burden at diagnosis (n = 91) | 0.637 | |||
| MTB RIF-high | 58 (63.7) | 36 (63.2) | 22 (64.7) | |
| MTB RIF-medium | 20 (22.0) | 14 (24.6) | 6 (17.7) | |
| MTB RIF-low | 13 (14.3) | 7 (12.3) | 6 (17.7) | |
| Chest X-ray (n = 60) | 58 (96.7) | 36 (94.7) | 22 (100) | 0.274 |
| Abnormal | ||||
| Cavitation (n = 31) | ||||
| Upper zone | 23 (74.2) | 16 (88.9) | 7 (53.9) | 0.028 |
| Middle zone | 13 (41.9) | 7 (38.9) | 6 (46.2) | 0.686 |
| Lower zone | 5 (16.1) | 2 (11.1) | 3 (23.1) | 0.371 |
| Infiltration (n = 57) | ||||
| Upper zone | 48 (84.2) | 32 (91.4) | 16 (72.7) | 0.059 |
| Middle zone | 47 (82.5) | 28 (80.0) | 19 (86.4) | 0.539 |
| Lower zone | 36 (63.2) | 22 (62.9) | 14 (63.6) | 0.953 |
| Clinical Signs | ||||
| Night Sweat | 61 (65.6) | 37 (62.7) | 24 (70.6) | 0.441 |
| Chest Pains | 70 (75.3) | 47 (79.7) | 23 (67.7) | 0.196 |
| Weight Loss | 89 (95.7) | 58 (98.3) | 31 (91.2) | 0.103 |
| Cough (>2 weeks) | 77 (82.8) | 49 (83.1) | 28 (82.4) | 0.932 |
| Dyspnoea | 50 (53.8) | 31 (52.5) | 19 (55.9) | 0.756 |
| Hemoptysis | 8 (8.6) | 3 (5.1) | 5 (14.7) | 0.111 |
| Fever | 26 (28.0) | 17 (28.8) | 9 (26.5) | 0.808 |
| Myalgia | 26 (28.0) | 17 (28.8) | 9 (26.5) | 0.808 |